Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Lower <i>SERPINA1</i> expression in tumor but higher in adjacent non-tumor lung tissues (<i>n</i> = 351, <i>p</i> = 0.016) as well as higher serum levels of AAT protein (<i>n</i> = 170, <i>p</i> = 0.033) were associated with worse survival rates.
|
31487965 |
2019 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The plasma A1AT activity and concentrations were positively correlated with the tumor stage and well-discriminated between early and advanced stages.
|
31183614 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The aim of the study was to evaluate the expressions of Serpin A1 in LS, premalignant vulvar lesions, and vSCC using immunohistochemistry (IHC) and serum analysis, and to compare Serpin A1 stainings to the tumor markers p53 and p16.
|
30607583 |
2019 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Using female transgenic 'AT-ATX' mice, whereby human wild-type autotaxin is expressed in liver under the control of the alpha-1 antitrypsin promoter, transgenic animals express augmented autotaxin in circulation and a percentage develop tumors.
|
29859298 |
2018 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Importantly, high A1AT expression correlated with increased tumor stage, elevated p53 staining and shorter overall survival in lung adenocarcinoma patients.
|
28368395 |
2017 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Herein, we first examined AAT expression in a panel of formalin-fixed paraffin-embedded tumor tissues from 88 lung adenocarcinoma patients undergoing curative resection, using immunohistochemical methods.
|
28440399 |
2017 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Here, we identified that GBM following AAT (Vatalanib) acquired an alternate mechanism to support tumor growth, called vascular mimicry (VM).
|
27990624 |
2017 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Immunohistochemically, strong diffused positive for vimentin, desmin, ALK (nuclear membrane staining pattern) and AAT, focally positive for CD99 and CD30, were showed, Ki67 index was about 20%; Especially, WT-1 and D240 were focally expressed in this tumor.
|
26097614 |
2015 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Immunohistochemistry (IHC) analysis of the tumor and immunocytochemistry (ICC) analysis of UACC-SARC1 revealed shared expression of vimentin, osteonectin, CD68, Ki67 and PTEN but tumor-restricted expression of the histiocyte markers α1-antitrypsin and α1-antichymotrypsin.
|
25644184 |
2015 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Enhanced serpinA1 expression was significantly associated with increased tumour size, advanced T stage, perineural invasion, lymphovascular invasion, lymph node metastases, and shorter overall survival.
|
25211665 |
2014 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Immunohistochemistry of the tumor was positive for β-catenin (nuclear and cytoplasmic reactivity), α1-antitrypsin, vimentin, CD56, synaptophysin (focal weak), CD10.
|
25186079 |
2014 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Expression of eight genes (ABCC3, C1orf9, C6orf62, FGFR1OP2, HEY2, NDOR1, STAT3, and UCP3) in normal tissue and six genes (ANKRD46, CD47, HNRNPH1, NDOR1, SCEL, and SERPINA1) in tumour tissue was significantly associated with I-131.
|
24045656 |
2013 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Knockdown of α1-antitrypsin by siRNA further enhanced the tumor cell proliferation induced by neutrophil elastase and significantly blocked the anti-proliferation effect of curcumin against neutrophil elastase.
|
22507634 |
2012 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In LMAN1-deficient colorectal cancer cell lines, secretion of the LMAN1 client protein alpha-1-antitrypsin (A1AT), an inhibitor of angiogenesis and tumor growth, was significantly impaired but could be restored upon LMAN1 re-expression.
|
19118014 |
2009 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
After stimulation with oncostatin M (OSM), interleukin-6 (IL-6) or tumor necrotic factor alpha (TNF alpha), hAE cells increased the expression of AAT, while the expression of MMP9 was reduced by OSM and induced by TNF alpha.
|
19073710 |
2009 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
These data, together with the pattern of expression of serpin A1 we observed in ALK+ tumors, suggest that serpin A1 has an invasion-promoting effect in ALK+ ALCL.
|
16900211 |
2006 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
The polymorphism AAT > AGT at codon 363 (N363S) was found in 17% and the polymorphism AAT > AAC at codon 766 (N766N) in 11% of tumours, both in heterozygous state.
|
12390341 |
2002 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Alpha-1-antitrypsin (A1AT) and glutathione S-transferase pi (GSTP) were significantly up-regulated in all 5 tumors.
|
12488200 |
2002 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
For comparison with reg, alpha-1-antitrypsin (AAT), lysozyme, chromogranin A (CMG), CA 19-9, carcinoembryonic antigen (CEA), cytokeratin, vimentin, and alpha-fetoprotein (AFP) were assessed in those tumors.
|
1525759 |
1992 |